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UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION (UCBT)
WITHOUT SEROTHERAPY IN CHILDREN IS ASSOCIATED WITH RAPID
CD4 + T-CELL RECONSTITUTION AND RECOVERY OF ANTI-VIRAL RE-
SPONSES
Chiesa, R., Rao, K., Hewitt, A., Qasim, W., Amrolia, P.J., Goulden, N.,
Veys, P. Great Ormond Street Hospital, London, United Kingdom
Conventional UCBT with serotherapy is characterized by a low
incidence of GvHD but delayed immune reconstitution and high in-
fection-related mortality. We evaluated early immune reconstitu-
tion, infection-related mortality and incidence of GvHD in
children undergoing unrelated UCBT without serotherapy.
13 children with a median age of 12 months (range, 1-144) un-
derwent an unrelated UCBT for SCID (7), high risk/relapsed
ALL (4) and secondary AML (2). Conditioning was myeloablative
in 11 patients, reduced intensity in 1 patient and none in 1. HLA
matching was 6/6, 5/6 and 4/6 in six, six and four cases respectively
(3 double cord infusions). GvHD prophylaxis was cyclosporine/
mycophenolate mofetil (11), cyclosporine/methylprednisolone (1)
and cyclosporine (1). The median number of nucleated, CD34+
and CD3+ cells infused was 8.8  107/kg (range, 4.7-17.72), 3.8
 105/kg (range, 1.23-11.95) and 6.1  106/kg (range, 1.9-24.45),
respectively.
Median time to myeloid and platelet engraftment was 21 (range,
13-35) and 39 (range, 32-71) days, respectively. One patient died
from conditioning related toxicity. 12 patients are alive and in remis-
sion with a median follow up of 12 months (range, 3-60). 10 patients
have full donor chimerism while 2 patients have full donor chime-
rism in the lymphoid compartment only.
The incidence of aGvHD was high (grade II n5 7; grade III-IV
n5 3) but generally responded promptly to steroids. At last fol-
low-up, 8 patients are off immunosuppression, and one developed
limited cGvHD. There was no infection-related mortality and low
incidence of viral reactivations (n5 3 adenoviraemia).
Our most striking finding was of rapid CD4 +T-cell reconstitu-
tion. The median CD3+, CD4+ and CD8+ counts within 2 months
postUCBTwas 0.83 x109cells/L (range, 0.44-2.44), 0.63 x109cells/L
(range, 0.06-1.89), and 0.15 x109cells/L (range, 0.01-1.21) respec-
tively. This contrasts to a similar group of children (7) who under-
went unrelated UCBT with serotherapy in whom the median
CD3+/CD4+/CD8+ counts at 2 months were 0.07/0.03/0.03
x109cells/L. In our cohort 5 of 9 evaluable patients had normal
CD4+ counts by 5-6 months post transplant.
Adenovirus specific T cells were detected as early as 60 days post
transplant, and all 3 cases of adenoviraemia resolved rapidly.
We conclude that unrelatedUCBTwithout serotherapy, while as-
sociated with a higher incidence of steroid-responsive aGvHD, re-
sults in rapid CD4 +T-cell reconstitution and a low incidence of
viral complications.176
ENHANCED IMMUNE RECONSTITUTION DESPITE IN VIVO LYMPHO-DE-
PLETION AS PART OF ACUTE GRAFT VS HOST DISEASE AGVHD PROPHY-
LAXIS IN UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTS
UHSCT
Gul, Z.1, Abdul-Hussein, M.2, Abidi, M.1, Ayash, L.1, Lum, L.1,
Chen,W.3, Uberti, J.1, Ratanatharathorn, V.1, Al-Kadhimi, Z.1 1Wayne
State University/Karmanos Cancer Center, Detroit, MI; 2Sinai Grace
Hospital, Detroit, MI; 3Karmanos Cancer Center, Detroit, MI
Background: Slow lymphocyte recovery and low immunoglobulin
levelspostUHSCTmaycontribute toworse clinical outcomes.(relapse
and survival). We reported preliminary low rates of aGVHD, infec-
tions and treatment related toxicity with the use of Thymoglobulin
(4.5 mg/kg divided doses on days -1,-2, & -3), Tacrolimus and Siroli-
mus for aGVHD prophylaxis in adult UHSCT. Here we explored
the differences in absolute lymphocyte count ALC and Immunoglob-
ulin IgG levels at three time points (days 30, 60, & 90) post transplant
in relation to a large comparable groupof historical patients at our cen-
ter treatedwithTacrolimusandMycophenolate (TM)asaGVHDpro-
phylaxis.
Methods: Analyses are made on non-censored and censored data
(for aGVHD and relapse events) in TTS vs TM groups. The
original measurements ALC & IgG are tested at each time point(30, 60, and 90 days) for group differences via the Student’s t-test.
The dichotomized measurements (thresholds of ALC at 1000/ml
and IgG at 500/ml) are compared between two groups using Fish-
er’s exact test. The difference in the linear trends of ALC and IgG
thresholds between two treatment groups is investigated using lo-
gistic model and Wald Chi-square test for interaction of day and
group.
Results:There were 25 patients on TTS and 72 on TM. The in-
cidence of aGVHD was higher in TM 77.8% compared to 24%
in TTS (P\ 0.0001). No difference in the relapse rate (12.5%
TM vs 16% TTS P 0.7354). We observed a higher mean IgG
level in TTS vs TM groups at days 60 & 90 post transplant (P
0.0558 & 0.0087), In addition to higher percentage of patients
with an IgG level. 500 mg/ml on days 30 & 90 (P 0.0358,
0.0078). When patients with aGVHD & relapse were excluded
from both groups, there was no statistical deference between
TTS & TM. Furthermore the percentage of patients with
ALC. 1000/ml in TTS nearly tripled in a linear fashion from
day 30 to day 90 (20 to 59% trend test P 0.0086 for non cen-
sored & 17% to 58% P 0.0081 for censored), while the same per-
centage nearly doubled for TM group between days 30 and 90(21
to 46% P 0.0025 for non censored & 26 to 63 P 0.0017 for cen-
sored).
Conclusion: These early results suggest that there is an enhanced
immune reconstitution in the experimental group TTS despite lym-
pho-depletion, as shown by higher IgG as well as a steep linear recov-
ery of ALC. We postulate that the decreased aGVHD in TTS
resulted in less need for additional immune suppression and hence
improved immune reconstitution.
Comparing dichotomized biomarkers between Experimental
and historical control groups on noncensored data
Control ExperimentalthPercent
above
resholdp
value thPercent
above
resholdp
valuep
valueImmunoglobulins5.500
Day 30 76% 0.3591* 96% 0.6334* 0.0358†
Day 60 78% 92% 0.2172†
Day 90 69% 100% 0.0078†
Lymphocytes5.1000 0.4332 ‡
Day 30 21% 0.0025* 20% 0.0086* 1.0000†
Day 60 47% 50% 0.3322†
Day 90 36% 59% 0.4164†† P-values from two-sided Fisher’s exact test for the difference between
two groups at each time point. * P-values from the Cochran-Armitage
Trend Test for the linear trend across 3 time points within each group
‡: P-values from theWald Chi-square test for linear trend difference be-
tween two groups177
THE ABSENCE OF VASOACTIVE INTESTINAL PEPTIDE AUGMENTS ALLO-
REACTIVITY AND THE ANTI-VIRAL RESPONSE IN A BONE MARROW
TRANSPLANT SETTING
Li, J.-M.1, Shin, K.1, Southerland, L.2, Hossain, S.1, Harris, W.1,
Waschek, J.3, Waller, E.K.1 1Winship Cancer Institute, Emory Univer-
sity, Atlanta, GA; 2Duke University, Durham, NC; 3University of Cal-
ifornia, Los Angeles, CA
Backgrounds:Vasoactive intestinal peptide (VIP) can lead to the gen-
eration of regulatory dendritic cells (DC). In this study, we used DC
and T-cells from VIP-knockout (VIP-KO) mice to investigate the ef-
fects of VIP on allogeneic and anti-viral immune responses in trans-
plant recipients.
Methods: 5 106 BM and 1, 3, 8 106 splenocytes (SP) from VIP-
KO and WT donors, single VIP-KO donors, single WT donors, or
single VIP-heterozygous donors were transplanted in B6/ B10BR
alloBMT and B6/ B6 synBMT models. Survival and GvHD were
S224 Poster Session Iassessed.VIP-KOmice,WTlittermates, and recipientswere infected
with 5 104 PFU murine cytomegalovirus (mCMV) and T cell re-
sponse to viral antigen was measured by flow cytometry for mCMV
peptide-MHC class I-tetramer+ CD8+ T-cells at day 0, 3, 7, 10, and
day 15 post infection or 80, 83, 87 and 101 days post-transplant (in-
fection at day 80 post-transplant). Day 15 post mCMV challenge,
VIP-KO andWTmice were euthanized. DC and T-cells were puri-
fied from BM and SP by FACS andMACS, respectively. 2 105/mL
DC treated with 1 104 PFU mCMV peptide-expressing Listeria-
CMV construct and incubated with 2 106/mL T-cells at 37 C.
Cultured 3 days and 7 days, cells were harvested and analyzed with
DC and T-cell surface marker, tetramer, and intracellular cytokines
by flow cytometry.
Results: allogeneic recipients of VIP-KO BM and VIP-KO SP de-
veloped more GvHD than recipients of WT grafts using a lower
dose of donor SP (1 106), while there was no difference in survival.
The GvHD scores and the percentage of survival showed no differ-
ence among other syngeneic or allogeneic BMT settings.The spe-
cific anti-viral immunity was similar among the non-transplanted
VIP-KO mice, and allogeneic and syngeneic transplant recipients
of VIP-KO donor cells. 3 and 7 days post culture, VIP-KO DC ex-
pressed higher-level of CD80, MHC-II and lower-level of PD-L1,
VIP-KOT-cells had higher-level of tetramer+ CD8+ T-cells and in-
tracellular IFN-g, lower-level of IL-4 and IL-5, PD1, and ICOS.
Taken together, these observations suggest that VIP expressed on
immune cells suppresses anti-viral immune responses and Th1 po-
larization.
Conclusion: The anti-viral immune responses of VIP-KO immune
cells were independent allogeneic immunity; VIP expressed by neu-
rocrine cells inWT recipients did not compensate for the lack of VIP
in mice transplanted with VIP-KO cells. Modulation of the VIP
pathway is a novel method to regulate post-transplant immunity al-
logeneic transplant recipients.178
THE LIVER MAINTAINS STRONG POPULATIONS OF INNATE IMMUNE
CELLS THAT CONTRIBUTE TO HOST PROTECTION AFTER ALLOGENEIC
HEMATOPOIETIC CELL TRANSPLANTATION
Mueller, A.M.S.1,2, Tran, P.1, Shizuru, J.A.1 1Stanford School of Med-
icine, Stanford, CA; 2University Medical Center, Freiburg i.Br., Ger-
many
The liver is a critical immunocompetent organ armed with lym-
phocytes, natural killer (NK) cells, and a variety of antigen-present-
ing cells (APC), including resident macrophages, called Kupffer cells
(KC). Exposed to large amounts of both destructive and harmless
toxins and antigens, the liver must provide immunogenic and tolero-
genic immunity. Here, we studied the role of the liver after hemato-
poietic cell transplantation (HCT). Lethally irradiated BALB.K
mice received MHC-matched, purified hematopoietic stem cells
(HSC; cKit + Sca1 + Thy1.1loLin-) +/- splenocytes (SP) from
AKR/J donors. Ficoll-separated mononuclear cells (MNC) from
PBS flushed livers were FACS analyzed post-HCT (pTX). In recip-
ients ofHSC + SP the liver was amajor target organ of acute graft-vs-
host disease (GVHD) with prominent donor T cell (TC) expansion,
while NK cell (DX5 + CD122+) and KC (CD11b + F4/80+) levels
were severely decreased. HSC-derived donor cells were rare. In con-
trast, mice given pure HSC showed no signs of GVHD, and early
pTX high proportions of NK cells and KC were present within
the livers. NK cells comprised up to 30% of cells and were mixed
donor/host type, while KC were donor derived at 6w pTX. We hy-
pothesized that rapid regeneration of KC may shield against the
pathogen and toxin load entering the circulation from irradiation-
damaged intestines. In fact, when KC reconstitution was suppressed
by silica administration mice displayed severe weight loss, hunched
posture, ruffled fur, diarrhea, and a .50% mortality. Survivors sta-
bilized d12, presumably with gut recovery. To test if regenerating
APC could protect against GVHD, a lethal dose of SP was given at 0,
4, 7, or 10d pTX, time points at which control livers contained 0, 11,
25, 32% KC, respectively. All mice receiving SP on d0 died, but
death occurred in only 50%, 17% and 0% of mice when SP were
given on d4, 7, and 10, respectively. Although donor chimerism de-
creased with delayed SP injection, lymphocyte reconstitution wasimproved. In conclusion, the role of the liver as an immunologically
active organ after ‘conventional’ HCT is often masked by donor TC
expansion and GVHD. Rapid recovery of innate liver immunity may
protect the host from endotoxemia and mediate tolerance between
donor and host. Elevated proportions of NK cells, which are lacking
in GVHD affected mice suggest another beneficial mechanism. Im-
munohistochemical studies for a better quantitative assessment of
resident liver immune cells are underway.179
A TREND FOR BETTER IMMUNE RECONSTITUTION AND LOWER INCI-
DENCE OF INFECTIONS AFTER UNRELATED CORD BLOOD TRANSPLAN-
TATION IN CHILDREN COMPARED TO ADULTS
Legrand, F.1, Vincent, E.2, Larosa, F.1, Grenouillet, F.3, Coaquette, A.4,
Masson, E.5, Ledu, K.1, Sass, P.5,6, Deconinck, E.1, Rohrlich, P.S.2,6 1Hoˆ-
pital Jean Minjoz, Besancon, France, Metropolitan; 2Hoˆpital Saint Jac-
ques, Besancon, France, Metropolitan; 3Hopital Jean Minjoz, Besancon,
France, Metropolitan; 4Hopital Saint Jacques, Besancon, France, Metro-
politan; 5EFS, Besancon, France, Metropolitan; 6EFS, Besancon, France,
Metropolitan
In umbilical cord blood transplantation (UCBT), the lower in-
fused cell dose might lead to an increased infectious risk. To get fur-
ther insights on this issue, we retrospectively analyzed infectious
events and immune restoration in 35 consecutive patients (pts)
treated by UCBT from Jan 2005 to Dec 2008 in the University Hos-
pital of Besanc¸on.
There were 7 children and 28 adults aged 6 to 62 y (median 35y).
All pts suffered frommalignant diseases. Nine pts were in CR1, 10 in
CR2 and 16 in$CR3 or in PR.Nine pts were CMV+ and 29EBV+. A
myeloablative conditioning regimen with 12 GY TBI (16pts) or Bu-
sulfan (2 pts) + 120 mg/kg cyclophosphamide + 75 mg/m2 fludara-
bine was given to 18 pts, one child received ALG instead of
fludarabine. A fludarabine based reduced intensity conditioning
(RIC) was given to 17 pts. There were 29 double and 6 single unit
transplants. The median follow-up is 638 days (259-1449).
All pts engrafted except 3 after RIC. Fifteen pts died (43%), 10 of
relapse, 4 of infection (1 ARDS,1 zygomycosis, 1 fusariosis and 1
HHV6 encephalitis) and 1 died of post-conditioning toxicity. There
were 8 infectious events in 7 children, (mean 1.14/pt) with 1 death in
the pt who received ALG and 86 infectious events in 28 adults (mean
3.07/pt) causing 3 deaths.
Viral infections occurred in 27 pts (77%) in majority before D100
(73%). BKV+ hemorrhagic cystitis (HC) occurred in 13 pts, VZV (6),
CMV (5), HHV6 (1), HSV (1), and RSV (1). We recorded 22 docu-
mented bacterial infections caused by 13 Gram negative and 9 Gram
positive agents. Invasive fungal infections were diagnosed in 9 pts
(26%) with 6 proven or probable aspergillosis, 2 fungal septicaemias
and 1 zygomycosis. Fungal infections seemed more frequent in pts
experiencing chronic GVHD (35% versus 21.4%, hazard ra-
tio5 1.6, p5 0.91).
The immune reconstitution appeared quicker in children, the me-
dian CD4 T cell count at 3-6-12 months post UCBTwas 224-1008-
1333/mm3 in children and 119-216-364 in adults. Median B cell
count at 6 mo post UCBT was 868 in children versus 106 in adults.
Among the 20 survivors at 1 year post transplant, the vaccine re-
sponse was complete in 15 pts, incomplete in 2, non available in 3.
The lower incidence of infectious events in children might be due
to a better immune reconstitution. The overall infectious mortality
rate is relatively low (11%). The high prevalence of HC advocates
for a prospective follow-up of BK virus and the high rate of Zoster
warrants preventive strategies.LATE EFFECTS/QUALITY OF LIFE
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A PROSPECTIVE STUDY OF IRON-OVERLOAD (IO) MANAGEMENT IN AL-
LOGENEIC HEMATOPOIETIC-CELL TRANSPLANT (ALLO HCT) SURVIVORS
Majhail, N.S.1, Lazarus, H.M.2, Burns, L.J.1 1University of Minnesota,
Minneapolis, MN; 2Case Western Reserve University, Cleveland, OH
While transfusional IO occurs in 30-60% of allo HCT survi-
vors, the treatment of post-HCT IO is not well described. We
